Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EnvarsusXR in Post Liver Transplant
NCT03386305Phase 3Active, not recruiting
- Sponsor
- Einstein Healthcare Network
- Start
- Dec 2017
- Primary completion
- Dec 2021
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in Liver transplant rejection, sponsored by Einstein Healthcare Network. Started Dec 2017; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT03386305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03386305.